Callan Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$3.19M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$2.07M |
| 3 |
Vanguard Total Bond Market
BND
|
+$2.06M |
| 4 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$1.63M |
| 5 |
Schwab Fundamental US Broad Market Index ETF
FNDB
|
+$1.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Broad Market ETF
SCHB
|
+$1.46M |
| 2 |
Schwab International Equity ETF
SCHF
|
+$742K |
| 3 |
Neurocrine Biosciences
NBIX
|
+$322K |
| 4 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$279K |
| 5 |
ResMed
RMD
|
+$263K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 86.18% |
| 2 | Healthcare | 12.42% |
| 3 | Real Estate | 0.47% |
| 4 | Financials | 0.35% |
| 5 | Materials | 0.26% |
Similar funds
Callan Capital's Q2 2016 Portfolio in Review
As of Q2 2016, Callan Capital held 71 positions worth $245M, up 2.7% from $239M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Callan Capital deployed $10.6M of net new capital in Q2 2016, opening 8 new positions and adding to 23 existing holdings. Its largest new stake was Schwab Fundamental US Broad Market Index ETF: 134,202 shares worth $1.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, up from 83% a quarter earlier, followed by Healthcare and Real Estate.
On the sell side, the largest reduction was Schwab US Broad Market ETF, an estimated $1.46M trimmed.
- Callan Capital's largest Q2 2016 buy was Schwab Fundamental US Broad Market Index ETF: 134,202 shares worth $1.34M.
- Callan Capital added most to Vanguard Short-Term Corporate Bond ETF in Q2 2016, an estimated $3.19M increase.
- Callan Capital's biggest Q2 2016 reduction was Schwab US Broad Market ETF, cutting an estimated $1.46M.
- Callan Capital fully exited Xtrackers MSCI EAFE Hedged Equity ETF in Q2 2016, selling an estimated $279K.
- Callan Capital's ten largest holdings make up 74% of its $245M portfolio in Q2 2016.
- Callan Capital opened 8 new positions and closed 3 in Q2 2016.
- Callan Capital's portfolio value rose 2.7% quarter-over-quarter to $245M.
Based on Callan Capital's 13F filing for Q2 2016, filed 12 Aug 2016.